Chan Soon-Shiong Institute for Medicine (CSSIFM)
Chan Soon-Shiong Institute for Medicine (CSSIFM)
El Segundo, California, United States2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IBRX-042 In Participants With HPV-Associated Tumors | HPV-Related Carcinoma | Active, not recruiting | Phase 1 | 2026-08-31 | NCT05976828 | |
| N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 2 | 2026-07-01 | NCT06061809 |